These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20588164)

  • 21. Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
    Dold L; Ahlenstiel G; Althausen E; Luda C; Schwarze-Zander C; Boesecke C; Wasmuth JC; Rockstroh JK; Spengler U
    PLoS One; 2015; 10(8):e0134158. PubMed ID: 26241854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human leukocyte antigen B distribution in HIV discordant cohort from India.
    Chaudhari DV; Chavan VR; Ahir SP; Kerkar SC; Mehta PR; Mania-Pramanik J
    Immunol Lett; 2013; 156(1-2):1-6. PubMed ID: 24029662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.
    Leitman EM; Hurst J; Mori M; Kublin J; Ndung'u T; Walker BD; Carlson J; Gray GE; Matthews PC; Frahm N; Goulder PJ
    J Infect Dis; 2016 Aug; 214(3):379-89. PubMed ID: 26951820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study.
    Yeo AE; Matsumoto A; Hisada M; Shih JW; Alter HJ; Goedert JJ
    Ann Intern Med; 2000 Jun; 132(12):959-63. PubMed ID: 10858179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control.
    van Manen D; Gras L; Boeser-Nunnink BD; van Sighem AI; Maurer I; Mangas Ruiz MM; Harskamp AM; Steingrover R; Prins JM; de Wolf F; van 't Wout AB; Schuitemaker H;
    AIDS; 2011 Nov; 25(18):2217-26. PubMed ID: 21860345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
    Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection.
    Vaidya SA; Streeck H; Beckwith N; Ghebremichael M; Pereyra F; Kwon DS; Addo MM; Rychert J; Routy JP; Jessen H; Kelleher AD; Hecht F; Sekaly RP; Carrington M; Walker BD; Allen TM; Rosenberg ES; Altfeld M
    Retrovirology; 2013 Nov; 10():139. PubMed ID: 24245727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
    Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
    Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Kiepiela P; Leslie AJ; Honeyborne I; Ramduth D; Thobakgale C; Chetty S; Rathnavalu P; Moore C; Pfafferott KJ; Hilton L; Zimbwa P; Moore S; Allen T; Brander C; Addo MM; Altfeld M; James I; Mallal S; Bunce M; Barber LD; Szinger J; Day C; Klenerman P; Mullins J; Korber B; Coovadia HM; Walker BD; Goulder PJ
    Nature; 2004 Dec; 432(7018):769-75. PubMed ID: 15592417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Super high-resolution single-molecule sequence-based typing of HLA class I alleles in HIV-1 infected individuals in Ghana.
    Nii-Trebi NI; Matsuoka S; Kawana-Tachikawa A; Bonney EY; Abana CZ; Ofori SB; Mizutani T; Ishizaka A; Shiino T; Ohashi J; Naruse TK; Kimura A; Kiyono H; Ishikawa K; Ampofo WK; Matano T
    PLoS One; 2022; 17(6):e0269390. PubMed ID: 35653364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disentangling human tolerance and resistance against HIV.
    Regoes RR; McLaren PJ; Battegay M; Bernasconi E; Calmy A; Günthard HF; Hoffmann M; Rauch A; Telenti A; Fellay J;
    PLoS Biol; 2014 Sep; 12(9):e1001951. PubMed ID: 25226169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion.
    Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-B polymorphism in Japanese HIV-1-infected long-term surviving hemophiliacs.
    Munkanta M; Terunuma H; Takahashi M; Hanabusa H; Miura T; Ikeda S; Sakai M; Fujii T; Takahashi Y; Oka S; Matsuda J; Ishikawa M; Taki M; Takashima Y; Mimaya J; Ito M; Kimura A; Yasunami M
    Viral Immunol; 2005; 18(3):500-5. PubMed ID: 16212528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection.
    Prentice HA; Lu H; Price MA; Kamali A; Karita E; Lakhi S; Sanders EJ; Anzala O; Allen S; Goepfert PA; Hunter E; Gilmour J; Tang J
    J Virol; 2016 Nov; 90(22):10423-10430. PubMed ID: 27630231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of TI8-8V mutant associated with long-term control of HIV-1 by cross-reactive HLA-B*51:01-restricted cytotoxic T cells.
    Kuse N; Akahoshi T; Gatanaga H; Ueno T; Oka S; Takiguchi M
    J Immunol; 2014 Nov; 193(10):4814-22. PubMed ID: 25305317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune markers and viral load after HIV-1 seroconversion as predictors of disease progression in a cohort of haemophilic men.
    Sabin CA; Devereux H; Phillips AN; Janossy G; Loveday C; Lee CA
    AIDS; 1998 Jul; 12(11):1347-52. PubMed ID: 9708415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.
    Lazaryan A; Song W; Lobashevsky E; Tang J; Shrestha S; Zhang K; Gardner LI; McNicholl JM; Wilson CM; Klein RS; Rompalo A; Mayer K; Sobel J; Kaslow RA; ;
    J Virol; 2010 Mar; 84(5):2610-7. PubMed ID: 20032191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection.
    Kosmrlj A; Read EL; Qi Y; Allen TM; Altfeld M; Deeks SG; Pereyra F; Carrington M; Walker BD; Chakraborty AK
    Nature; 2010 May; 465(7296):350-4. PubMed ID: 20445539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 envelope diversity 1 year after seroconversion predicts subsequent disease progression.
    Rachinger A; Kootstra NA; Gijsbers EF; van den Kerkhof TL; Schuitemaker H; van 't Wout AB
    AIDS; 2012 Jul; 26(12):1517-22. PubMed ID: 22555160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human leukocyte antigens class I and class II alleles associated with vertical human immunodeficiency virus transmission - an exploratory study from Mumbai, India.
    Ahir-Bist S; Chavan V; Padmaja Samant M; Nanavati R; Mehta P; Mania-Pramanik J
    Indian J Dermatol Venereol Leprol; 2023; 89(1):159. PubMed ID: 36331825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.